Publication:
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

Simple item page
dc.contributor.authorJ. Bousqueten_US
dc.contributor.authorJ. Farrellen_US
dc.contributor.authorG. Crooksen_US
dc.contributor.authorP. Hellingsen_US
dc.contributor.authorE. H. Belen_US
dc.contributor.authorM. Bewicken_US
dc.contributor.authorN. H. Chavannesen_US
dc.contributor.authorJ. Correia De Sousaen_US
dc.contributor.authorA. A. Cruzen_US
dc.contributor.authorT. Haahtelaen_US
dc.contributor.authorG. Joosen_US
dc.contributor.authorN. Khaltaeven_US
dc.contributor.authorJ. Malvaen_US
dc.contributor.authorA. Muraroen_US
dc.contributor.authorM. Noguesen_US
dc.contributor.authorS. Palkonenen_US
dc.contributor.authorS. Pedersenen_US
dc.contributor.authorC. Robalo-Cordeiroen_US
dc.contributor.authorB. Samolinskien_US
dc.contributor.authorT. Strandbergen_US
dc.contributor.authorA. Valiulisen_US
dc.contributor.authorA. Yorganciogluen_US
dc.contributor.authorT. Zuberbieren_US
dc.contributor.authorA. Bedbrooken_US
dc.contributor.authorW. Abereren_US
dc.contributor.authorM. Adachien_US
dc.contributor.authorA. Agustien_US
dc.contributor.authorC. A. Akdisen_US
dc.contributor.authorM. Akdisen_US
dc.contributor.authorJ. Ankrien_US
dc.contributor.authorA. Alonsoen_US
dc.contributor.authorI. Annesi-Maesanoen_US
dc.contributor.authorI. J. Ansoteguien_US
dc.contributor.authorJ. M. Antoen_US
dc.contributor.authorS. Arnavielheen_US
dc.contributor.authorH. Arshaden_US
dc.contributor.authorC. Baien_US
dc.contributor.authorI. Baiardinien_US
dc.contributor.authorC. Bacherten_US
dc.contributor.authorA. K. Baigenzhinen_US
dc.contributor.authorC. Barbaraen_US
dc.contributor.authorE. D. Batemanen_US
dc.contributor.authorB. Beghéen_US
dc.contributor.authorA. Ben Khederen_US
dc.contributor.authorK. S. Bennooren_US
dc.contributor.authorM. Bensonen_US
dc.contributor.authorK. C. Bergmannen_US
dc.contributor.authorT. Bieberen_US
dc.contributor.authorC. Bindslev-Jensenen_US
dc.contributor.authorL. Bjermeren_US
dc.contributor.authorH. Blainen_US
dc.contributor.authorF. Blasien_US
dc.contributor.authorA. L. Boneren_US
dc.contributor.authorM. Boninien_US
dc.contributor.authorS. Boninien_US
dc.contributor.authorS. Bosnic-Anticevitchen_US
dc.contributor.authorL. P. Bouleten_US
dc.contributor.authorR. Bourreten_US
dc.contributor.authorP. J. Bousqueten_US
dc.contributor.authorF. Braidoen_US
dc.contributor.authorA. H. Briggsen_US
dc.contributor.authorC. E. Brightlingen_US
dc.contributor.authorJ. Brozeken_US
dc.contributor.authorR. Buhlen_US
dc.contributor.authorP. G. Burneyen_US
dc.contributor.authorA. Bushen_US
dc.contributor.authorF. Caballero-Fonsecaen_US
dc.contributor.authorD. Caimmien_US
dc.contributor.authorM. A. Calderonen_US
dc.contributor.otherCHU Montpellieren_US
dc.contributor.otherMACVIA-LRen_US
dc.contributor.otherVieillissement et Maladies Chroniques. Approches Epidemiologiques et de Sante Publiqueen_US
dc.contributor.otherUniversite de Versailles Saint-Quentin-en-Yvelinesen_US
dc.contributor.otherDepartment of Healthen_US
dc.contributor.otherNational Health Serviceen_US
dc.contributor.otherKU Leuvenen_US
dc.contributor.otherEuropean Academy of Allergy and Clinical Immunologyen_US
dc.contributor.otherAcademic Medical Centre, University of Amsterdamen_US
dc.contributor.otherEuropean Respiratory Societyen_US
dc.contributor.otheriQ4U Consultants Ltden_US
dc.contributor.otherLeiden University Medical Center - LUMCen_US
dc.contributor.otherGlobal Alliance Against Chronic Respiratory Diseases (GARD)en_US
dc.contributor.otherInternational Primary Care Respiratory Groupen_US
dc.contributor.otherUniversidade do Minho, Escola de Ciencias da Saudeen_US
dc.contributor.otherUniversidade Federal da Bahiaen_US
dc.contributor.otherGARD Executive Committeeen_US
dc.contributor.otherEIP on AHA Commitment for Actionen_US
dc.contributor.otherSkin and Allergy Hospitalen_US
dc.contributor.otherUniversity Hospital of Ghenten_US
dc.contributor.otherUniversidade de Coimbra, Faculdade de Medicinaen_US
dc.contributor.otherAgeingatCoimbra Reference Siteen_US
dc.contributor.otherAzienda Ospedaliera Di Padovaen_US
dc.contributor.otherCaisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR)en_US
dc.contributor.otherEFA European Federation of Allergy and Airways Diseases Patients' Associationsen_US
dc.contributor.otherSyddansk Universiteten_US
dc.contributor.otherCentro Hospitalar e Universitario de Coimbraen_US
dc.contributor.otherMedical University of Warsawen_US
dc.contributor.otherHelsingin Yliopistoen_US
dc.contributor.otherOulun Yliopistoen_US
dc.contributor.otherEuropean Unionen_US
dc.contributor.otherVilniaus universitetasen_US
dc.contributor.otherEuropean Academy of Paediatrics (EAP/UEMS-SP)en_US
dc.contributor.otherCelal Bayar Universitesien_US
dc.contributor.otherTurkish Thoracic Societyen_US
dc.contributor.otherCharité – Universitätsmedizin Berlinen_US
dc.contributor.otherSecretary General of the Global Allergy and Asthma European Network (GA2LEN)en_US
dc.contributor.otherMedizinische Universitat Grazen_US
dc.contributor.otherInternational University of Health and Welfareen_US
dc.contributor.otherUniversitat de Barcelonaen_US
dc.contributor.otherCentro de Investigacion Biomedica en Red de Enfermedades Respiratoriasen_US
dc.contributor.otherUniversity of Zurichen_US
dc.contributor.otherInsermen_US
dc.contributor.otherClinica Quironen_US
dc.contributor.otherCentre de Recerca en Epidemiologia Ambiental, Barcelonaen_US
dc.contributor.otherHospital del Maren_US
dc.contributor.otherCIBER Epidemiologia Y Salud Publicaen_US
dc.contributor.otherUniversitat Pompeu Fabra Barcelonaen_US
dc.contributor.otherDigi Healthen_US
dc.contributor.otherDavid Hide Asthma and Allergy Research Centreen_US
dc.contributor.otherChinese Medical Associationen_US
dc.contributor.otherOspedale Policlinico San Martinoen_US
dc.contributor.otherEuroAsian Respiratory Societyen_US
dc.contributor.otherFaculdade de Medicina, Universidade de Lisboaen_US
dc.contributor.otherUniversity of Cape Townen_US
dc.contributor.otherUniversita degli Studi di Modena e Reggio Emiliaen_US
dc.contributor.otherUniversite de Tunis El Manar, Hopital Abderrahmene Mamien_US
dc.contributor.otherNational Institute of Diseases of the Chest and Hospitalen_US
dc.contributor.otherLinköpings universiteten_US
dc.contributor.otherUniversität Bonnen_US
dc.contributor.otherOdense Universitetshospitalen_US
dc.contributor.otherSkånes universitetssjukhusen_US
dc.contributor.otherCentre Européen de Recherche sur le Mouvement Humain, Université de Montpellieren_US
dc.contributor.otherUniversità degli Studi di Milanoen_US
dc.contributor.otherUniversità degli Studi di Veronaen_US
dc.contributor.otherUniversità degli Studi di Roma La Sapienzaen_US
dc.contributor.otherUniversità degli Studi della Campania Luigi Vanvitellien_US
dc.contributor.otherThe University of Sydneyen_US
dc.contributor.otherUniversité Lavalen_US
dc.contributor.otherUniversity of Glasgowen_US
dc.contributor.otherUniversity Hospitals of Leicester NHS Trusten_US
dc.contributor.otherUniversity of Leicesteren_US
dc.contributor.otherMcMaster University, Faculty of Health Sciencesen_US
dc.contributor.otherJohannes Gutenberg Universität Mainzen_US
dc.contributor.otherNational Heart and Lung Instituteen_US
dc.contributor.otherGlaxoSmithKline plc.en_US
dc.contributor.otherMedical Research Councilen_US
dc.contributor.otherRoyal Brompton Hospitalen_US
dc.contributor.otherCentro Medico Docente La Trinidaden_US
dc.contributor.otherUniversity of Liverpoolen_US
dc.contributor.otherUniversidade Federal de Minas Geraisen_US
dc.contributor.otherRégion Languedoc Roussillonen_US
dc.contributor.otherOslo University Hospitalen_US
dc.contributor.otherAllergy & Asthma Associates of Southern Californiaen_US
dc.contributor.otherRegional Ministry of Equalityen_US
dc.contributor.otherUniversity of South Florida, Tampaen_US
dc.contributor.otherUniversidad Simón Bolívaren_US
dc.contributor.otherAsma e Immunologiaen_US
dc.contributor.otherPanepistimio Kritisen_US
dc.contributor.otherCapital Institute of Pediatricsen_US
dc.contributor.otherTbilisi State Medical Universityen_US
dc.contributor.otherPulmonolory Research Institute FMBAen_US
dc.contributor.otherLatvian Psychiatric Associationen_US
dc.contributor.otherNova Southeastern Universityen_US
dc.contributor.otherImperial College Londonen_US
dc.contributor.otherKarolinska Instituteten_US
dc.contributor.otherTechnical University of Munichen_US
dc.contributor.otherCHU Strasbourgen_US
dc.contributor.otherEUREGHAen_US
dc.contributor.otherUniversity of Edinburghen_US
dc.contributor.otherUniversitatea de Medicina si Farmacie Iuliu Hatieganu din Cluj-Napocaen_US
dc.contributor.otherKronikguneen_US
dc.contributor.otherSorbonne Universiteen_US
dc.date.accessioned2018-12-11T02:59:58Z
dc.date.accessioned2019-03-14T08:01:40Z
dc.date.available2018-12-11T02:59:58Z
dc.date.available2019-03-14T08:01:40Z
dc.date.issued2016-07-29en_US
dc.description.abstract© 2016 The Author(s). Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.en_US
dc.identifier.citationClinical and Translational Allergy. Vol.6, No.1 (2016)en_US
dc.identifier.doi10.1186/s13601-016-0116-9en_US
dc.identifier.issn20457022en_US
dc.identifier.other2-s2.0-85006427875en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/40774
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85006427875&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleScaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)en_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85006427875&origin=inwarden_US

Files

Collections

Scopus 2016-2017